Search clinical trials for: low dose BI 10773 placebo

Total 3419 results

Israel Institute for Biological Research (IIBR)

Completed

Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

Covid19

Israel
Tatyana Zubkova

Completed

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Respiratory Syncytial Virus Infections

Russian Federation
Sahlgrenska University Hospital, Sweden
MetaboGen AB

Completed

Tolerability and Risk of Adverse Events With a Probiotic Supplement

Healthy Individuals

Sweden
Access Business Group
Clinical Research Laboratories

Completed

Evaluation of Skin Attributes Following Dietary Supplement Consumption

Skin Condition
Sean Liu

Active, not recruiting

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

SARS-CoV-2

United States
Kyoung Ho Lee, MD
Seoul National University Bundang Hospital; Ministry of Health & Welfare, Korea and other collaborators

Completed

Low vs. Standard Dose CT for Appendicitis Trial (LOCAT)

Appendicitis

Korea, Republic of
Boehringer Ingelheim

Not yet recruiting

A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

Obesity
Chinook Therapeutics, Inc.

Active, not recruiting

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

IgA Nephropathy

Korea, Republic of, United States, United Kingdom
Boehringer Ingelheim
Eli Lilly and Company

Completed

Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls

Healthy | Diabetes Mellitus, Type 2

United States
Boehringer Ingelheim

Completed

A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects

Diabetes Mellitus, Type 2

Austria, Germany, Italy
Boehringer Ingelheim

Completed

Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration

Diabetes Mellitus, Type 1

Canada
Institute of Liver and Biliary Sciences, India

Completed

Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.

Spontaneous Bacterial Peritonitis

India
Boehringer Ingelheim

Completed

Pharmacokinetics of Faldaprevir of Soft Capsule

Healthy

China
Biogen

Completed

Phase 1 Study to Evaluate the PK, Safety, Tolerability of BIIB023 in Chinese, Japanese, and Caucasian Healthy Volunteers

Healthy Volunteers

Australia, China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Beijing Simoonrecord Pharmaceutical...

Completed

A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis

China
Charleston Laboratories, Inc

Completed

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

Pain | Nausea | Vomiting
Boehringer Ingelheim

Completed

Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers

Healthy
InnoCare Pharma Inc.
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluating Different Doses of Orelabrutinib in MCL

Mantle Cell Lymphoma

China
Gyroscope Therapeutics Limited
Novartis Pharmaceuticals

Active, not recruiting

EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (EXPLORE)

Dry Age-related Macular Degeneration

United States, Germany, United Kingdom, Spain, Poland, Australia, France, Netherlands
Lexeo Therapeutics

Recruiting

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

Friedreich Ataxia | Cardiomyopathy, Secondary

United States, Canada
Oblato, Inc.

Recruiting

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

Astrocytoma | Glioblastoma Multiforme | Oligodendroglioma | High-grade Glioma

United States
Montana State University

Completed

Impact of Cottonseed Oil on Oxidative Stress, Inflammation, and Metabolism

Inflammation | Healthy | Metabolic Syndrome | Oxidative Stress

United States
National Institute of Diabetes and Digestive and...
Washington University School of Medicine; University of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai and other collaborators

Completed

Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis (HEMO)

End Stage Renal Disease

United States
Boehringer Ingelheim

Completed

Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

Hepatic Insufficiency | Healthy

Romania
Sang-Won Um

Not yet recruiting

A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females

Health Risk Behaviors
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
University Hospital, Geneva

Completed

The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly (PneumOldCT)

Pneumonia

Switzerland
Oncology Teaching Hospital, Baghdad

Enrolling by invitation

Iraqi Trial for Lung Cancer Screening (ITLUCAS)

Lung Cancer

Iraq
University of Oxford

Completed

Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults (HIV-CORE 002)

HIV-1 Infections

United Kingdom
Hospices Civils de Lyon

Completed

Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in HHT Patient (ULD OSLER)

Telangiectasia, Hereditary Hemorrhagic | Rendu Osler Disease

France
Inotrem

Active, not recruiting

Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock (ASTONISH)

Shock, Septic

Belgium, France, Spain, Denmark, Finland, Ireland
Statens Serum Institut
Bill and Melinda Gates Foundation; Aurum Institute; Leiden University Medical... and other collaborators

Recruiting

First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b (nTB-01)

Healthy

South Africa
Vaxart

Completed

Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)

Respiratory Syncytial Virus (RSV)

United States
AC Immune SA
National Institute on Aging (NIA); Alzheimer's Disease Cooperative Study (ADCS) and other collaborators

Completed

Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome (3-Star)

Down Syndrome

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Hypersensitivity | Food Hypersensitivity | Hypersensitivity, Immediate | Peanut Hypersensitivity

United States
Ingredia S.A.

Completed

Investigation of Milk Peptides on Postprandial Blood Glucose Profile

Postprandial Hyperglycemia

Germany
Hocheol Kim

Completed

Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke

Ischemic Stroke

Korea, Republic of
Seoul National University Hospital
DongGuk University

Unknown

Effect of Ginseol Kg1 on Blood Pressure Lowering

Prehypertension | Hypertension, Stage I

Korea, Republic of
Ocugen

Recruiting

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis (OCU400)

Retinitis Pigmentosa | Leber Congenital Amaurosis

United States
Yantai Yuhuangding Hospital

Recruiting

Clinical Study of Allergic Rhinitis Therapy by Stem Cells

Allergic Rhinitis

China
RDC Clinical Pty Ltd

Recruiting

Effect of Maolactin on Gastrointestinal Tract (GIT) Health

Gastrointestinal Dysfunction

Australia
Karolinska Institutet

Completed

Validation of X-ray Protocols in Cleft Children

Evaluate CBCT Protocols in Subjective Image Quality

Sweden
Bioverativ, a Sanofi company

Completed

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

Hemophilia A

United States, Japan
ST Pharm Co., Ltd.

Recruiting

A Clinical Trial of STP0404 in Treatment-Naïve Adults With HIV-1 Infection

HIV-1-infection

United States
Cancer Institute and Hospital, Chinese Academy...
Shanxi Province Cancer Hospital; Beijing Tongren Hospital; Fujian Medical University...

Recruiting

Low-dose Radiotherapy in iNHL

Indolent Lymphoma | Low-dose Radiotherapy

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Locally Advanced Nasopharyngeal Carcinoma

China
The University of Queensland

Active, not recruiting

International Lung Screen Trial (ILST) (ILST)

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Neoplasms by Site | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Non-small Cell Lung Cancer | Smokers at Risk of Lung Cancer

Australia, Canada
Oslo University Hospital
Odense University Hospital

Completed

Diagnostic Performance of Low-Dose CT for Acute Abdominal Conditions (DETECT_Acute)

Abdominal Pain | Acute Pain | Acute Pancreatitis | Acute Cholecystitis | Acute Appendicitis

Norway, Denmark
Manchester University NHS Foundation Trust

Completed

Automated Low Dose Risk Assessment Mammography (ALDRAM) (ALDRAM)

Breast Cancer

United Kingdom

Search clinical trials for: low dose BI 10773 placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations